Skip to main content
Premium Trial:

Request an Annual Quote

Sense Proteomic Spins out of Procognia

NEW YORK (GenomeWeb News) – Sense Proteomic has spun out of parent firm Procognia to form a stand-alone company that will focus on using a protein array platform aimed at discovering biomarkers for cancer and auto-immune diseases.
 
The Maidenhead, UK-based company has turned to the private equity investment company Apax Partners for financial backing.
 
Financial details of the investment and the spin out were not disclosed.

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.